Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8713379rdf:typepubmed:Citationlld:pubmed
pubmed-article:8713379lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:8713379lifeskim:mentionsumls-concept:C0149649lld:lifeskim
pubmed-article:8713379pubmed:dateCreated1996-9-26lld:pubmed
pubmed-article:8713379pubmed:abstractTextEmboligenic aortopathies are defined as lesions of the aortic wall leading to the production of thromboatheromatous material which can migrate in fragments or entirely. Emboligenic aortopathy can occur in all parts of the aorta. Localized lesions are rare and usually involve the subrenal abdominal aorta or the isthma. Diffuse lesions involving several segments of the aorta are encountered more often. There are three anatomic types of lesions: ulcerated plaques, atheromatous ulcerations, an evrysmal disease of the aorta. Therapeutic indications depend on: 1) clinical presentation: fibrinocruoric emboli, distal microemboli, disseminated cholesterol emboli; 2) the unique or multiple nature of the emboli; 3) the anatomic lesion; 4) localization.lld:pubmed
pubmed-article:8713379pubmed:languagefrelld:pubmed
pubmed-article:8713379pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8713379pubmed:citationSubsetIMlld:pubmed
pubmed-article:8713379pubmed:statusMEDLINElld:pubmed
pubmed-article:8713379pubmed:issn0398-0499lld:pubmed
pubmed-article:8713379pubmed:authorpubmed-author:CormierJ MJMlld:pubmed
pubmed-article:8713379pubmed:authorpubmed-author:FichelleJ MJMlld:pubmed
pubmed-article:8713379pubmed:authorpubmed-author:MelkiJ PJPlld:pubmed
pubmed-article:8713379pubmed:authorpubmed-author:MarzellaNNlld:pubmed
pubmed-article:8713379pubmed:authorpubmed-author:CormierFFlld:pubmed
pubmed-article:8713379pubmed:authorpubmed-author:CormierEElld:pubmed
pubmed-article:8713379pubmed:authorpubmed-author:YooubiA AAAlld:pubmed
pubmed-article:8713379pubmed:issnTypePrintlld:pubmed
pubmed-article:8713379pubmed:volume21 Suppl Alld:pubmed
pubmed-article:8713379pubmed:ownerNLMlld:pubmed
pubmed-article:8713379pubmed:authorsCompleteYlld:pubmed
pubmed-article:8713379pubmed:pagination100-12lld:pubmed
pubmed-article:8713379pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8713379pubmed:meshHeadingpubmed-meshheading:8713379-...lld:pubmed
pubmed-article:8713379pubmed:meshHeadingpubmed-meshheading:8713379-...lld:pubmed
pubmed-article:8713379pubmed:meshHeadingpubmed-meshheading:8713379-...lld:pubmed
pubmed-article:8713379pubmed:meshHeadingpubmed-meshheading:8713379-...lld:pubmed
pubmed-article:8713379pubmed:meshHeadingpubmed-meshheading:8713379-...lld:pubmed
pubmed-article:8713379pubmed:meshHeadingpubmed-meshheading:8713379-...lld:pubmed
pubmed-article:8713379pubmed:meshHeadingpubmed-meshheading:8713379-...lld:pubmed
pubmed-article:8713379pubmed:year1996lld:pubmed
pubmed-article:8713379pubmed:articleTitle[Emboligenic aortopathies. Cholesterol embolisms: surgical treatment].lld:pubmed
pubmed-article:8713379pubmed:affiliationChirurgie Vasculaire, Clinique de la Défense, Nanterre.lld:pubmed
pubmed-article:8713379pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8713379pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:8713379pubmed:publicationTypeReviewlld:pubmed